Literature DB >> 22274855

Substantial dose reduction in modern multi-slice spiral computed tomography (MSCT)-guided craniofacial and skull base surgery.

G Widmann1, M Fasser, P Schullian, A Zangerl, W Puelacher, F Kral, H Riechelmann, W Jaschke, R Bale.   

Abstract

PURPOSE: Reduction of the radiation exposure involved in image-guided craniofacial and skull base surgery is an important goal. The purpose was to evaluate the influence of low-dose protocols in modern multi-slice spiral computed tomography (MSCT) on target registration errors (TREs).
MATERIALS AND METHODS: An anthropomorphic skull phantom with target markers at the craniofacial bone and the anterior skull base was scanned in Sensation Open (40-slice), LightSpeed VCT (64-slice) and Definition Flash (128-slice). Identical baseline protocols (BP) at 120  kV/100  mAs were compared to the following low-dose protocols (LD) in care dose/dose modulation: (LD-I) 100  kV/35ref. mAs, (LD-II) 80  kV/40 - 41ref. mAs, and (LD-III) 80  kV/15 - 17ref. mAs. CTDIvol and DLP were obtained. TREs using an optical navigation system were calculated for all scanners and protocols. Results were statistically analyzed in SPSS and compared for significant differences (p ≤ 0.05).
RESULTS: CTDIvol for the Sensation Open/LightSpeed VCT/Definition Flash showed: (BP) 22.24 /32.48 /14.32 mGy; (LD-I) 4.61 /3.52 /1.62 mGy; (LD-II) 3.15 /2.01 /0.87 mGy; and (LD-III) na/0.76 /0.76 mGy. Differences between the BfS (Bundesamt für Strahlenschutz) reference CTDIvol of 9 mGy and the lowest CTDIvol were approximately 3-fold for Sensation Open, and 12-fold for the LightSpeed VCT and Definition Flash. A total of 33 registrations and 297 TRE measurements were performed. In all MSCT scanners, the TREs did not significantly differ between the low-dose and the baseline protocols.
CONCLUSION: Low-dose protocols in modern MSCT provided substantial dose reductions without significant influence on TRE and should be strongly considered in image-guided surgery. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22274855     DOI: 10.1055/s-0031-1281971

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

1.  Ultralow dose dentomaxillofacial CT imaging and iterative reconstruction techniques: variability of Hounsfield units and contrast-to-noise ratio.

Authors:  Gerlig Widmann; Alexander Bischel; Andreas Stratis; Apoorv Kakar; Hilde Bosmans; Reinhilde Jacobs; Eva-Maria Gassner; Wolfgang Puelacher; Ruben Pauwels
Journal:  Br J Radiol       Date:  2016-01-21       Impact factor: 3.039

2.  Validity of linear measurements of the jaws using ultralow-dose MDCT and the iterative techniques of ASIR and MBIR.

Authors:  Asma'a A Al-Ekrish; Reema Al-Shawaf; Peter Schullian; Ra'ed Al-Sadhan; Romed Hörmann; Gerlig Widmann
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-06-02       Impact factor: 2.924

3.  CT analysis of the anterior nasal airway based on the direction of nasal airflow in patients with nasal obstruction and trauma controls.

Authors:  Aris I Giotakis; Gerlig Widmann; Erik Mallien; Felix Riechelmann; Helen Heppt; Herbert Riechelmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-15       Impact factor: 3.236

4.  Diagnostic reliability of low dose multidetector CT and cone beam CT in maxillofacial trauma-an experimental blinded and randomized study.

Authors:  Romke Rozema; Michiel Hj Doff; Peter Ma van Ooijen; Douwe Postmus; Henriëtte E Westerlaan; Martijn F Boomsma; Baucke van Minnen
Journal:  Dentomaxillofac Radiol       Date:  2018-05-31       Impact factor: 2.419

Review 5.  Diagnostic accuracy of physical examination findings for midfacial fractures: a systematic review and meta-analysis.

Authors:  Romke Rozema; Michiel H J Doff; Konstantina Delli; Frederik K L Spijkervet; Baucke van Minnen
Journal:  Clin Oral Investig       Date:  2022-03-17       Impact factor: 3.573

Review 6.  Ultralow Dose MSCT Imaging in Dental Implantology.

Authors:  Gerlig Widmann; Asma'a A Al-Ekrish
Journal:  Open Dent J       Date:  2018-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.